interaction between msc and nk cells
Reading File
Finding Sources
Searching PubMed
"mesenchymal stem cells" AND "natural killer cells" AND immunomodulation
Searching the Web
MSC NK cell interaction immunomodulation mechanisms 2024 2025
Reading Article
Reading Article
Reading Article
Reading Web Page
MSC NK cell interaction mechanisms immunomodulation
I now have enough information for a comprehensive answer. Here is a detailed synthesis:
MSC - NK Cell Interaction
Mesenchymal stem/stromal cells (MSCs) and natural killer (NK) cells engage in a bidirectional, context-dependent crosstalk that is one of the most complex axes in innate immunomodulation. The relationship is not simply suppressive or activating - it is dynamically regulated by the inflammatory environment, cell ratios, and activation states of both cell types.
1. MSC Susceptibility to NK Cell Killing
Under resting or low-activation conditions, MSCs express low levels of MHC class I (HLA-I) molecules. NK cells use inhibitory killer immunoglobulin-like receptors (KIRs) that are normally held in check by recognizing HLA-I on target cells. When HLA-I is low or absent ("missing self"), NK cells are released from inhibition and can kill the target.
- MSCs are therefore susceptible to NK cell-mediated lysis via activating receptors NKp30, NKp44, and NKp46 (natural cytotoxicity receptors), as well as NKG2D, which binds stress ligands (e.g., MICA/MICB) upregulated on MSCs.
- This makes freshly transplanted, "naive" MSCs potentially vulnerable to NK cell attack, especially in inflamed tissue.
Escape mechanism: When MSCs are exposed to IFN-γ (released by activated NK cells or T cells), they upregulate HLA-I expression dramatically. High HLA-I then engages KIRs on NK cells, promoting inhibition of NK cell cytolysis - a classic self-protection feedback loop.
2. MSC Suppression of NK Cells (Dominant Effect)
Under most co-culture and in vivo conditions, MSCs suppress NK cell function through both soluble factor-mediated and contact-dependent mechanisms.
Soluble/Paracrine Factors
| Factor | Effect on NK Cells |
|---|---|
| PGE2 (prostaglandin E2) | Inhibits NK cell proliferation, cytotoxicity, and IFN-γ production |
| IDO (indoleamine 2,3-dioxygenase) | Depletes tryptophan, inducing NK cell anergy |
| TGF-β1 | Downregulates NKG2D expression, reducing NK cytotoxicity |
| HGF (hepatocyte growth factor) | Inhibits NK activation and cytokine production |
| HLA-G5 (soluble) | Suppresses NK cytotoxicity and promotes tolerogenic NK phenotypes |
These factors act synergistically. MSCs inhibit IL-2-induced NK cell proliferation, blunt cytotoxic granule release, and reduce IFN-γ secretion - key effector functions of NK cells.
Contact-Dependent Mechanisms
- Direct cell-to-cell contact between MSCs and NK cells is required for full suppression. Some suppression persists in transwell systems (confirming soluble factor contributions), but is enhanced by physical contact.
- MSC expression of TLR3 and TLR4 (when activated by ligands such as poly I:C or LPS) can paradoxically increase NK cell suppression by boosting IDO and PGE2 secretion.
3. Bidirectionality: NK Cell Effects on MSCs
NK cells are not passive in this interaction. They actively modify MSC behavior:
- IFN-γ released by NK cells licenses MSCs to become more immunosuppressive (upregulates IDO, HLA-I, and PD-L1 on MSCs).
- NK cell-derived TNF-α can activate MSC immunosuppressive programs.
- At high NK:MSC ratios (NK cells outnumber MSCs substantially), NK cells overcome MSC suppression and can lyse them. At low NK:MSC ratios, MSC immunosuppression dominates.
- This ratio-dependent outcome has important implications for cell therapy dosing.
4. Context: Tumor Microenvironment (TME)
In the TME, MSCs are converted into tumor-associated MSCs (TA-MSCs), which are heavily skewed toward NK cell suppression:
- TA-MSCs produce high levels of PGE2, TGF-β1, and IDO, contributing to NK cell exhaustion and numerical decline within tumors.
- NK cells in the TME show downregulated activating receptors (NKG2D, NKp30), impaired degranulation, and reduced IFN-γ/TNF-α production - partly driven by TA-MSC signals.
- TA-MSCs may also induce regulatory NK cell phenotypes, shifting them from cytotoxic to tolerogenic.
This pathway is a major mechanism by which solid tumors evade innate immune surveillance, and is an active target for cancer immunotherapy strategies (e.g., combining MSC-blockade with CAR-NK therapy).
5. MSC Enhancement of NK Cell Function (Dual Role)
The interaction is not uniformly suppressive. In certain contexts, MSCs enhance NK cell activity:
- MSC-derived IL-6 and co-stimulatory signals can support NK cell survival and maintenance in the bone marrow niche.
- When NK cells are stimulated with IL-12 + IL-18, MSCs can enhance rather than inhibit IFN-γ secretion - a potentially beneficial effect for defense against infection and tissue repair.
- MSC-derived exosomes contain bioactive factors (miRNAs, proteins) that can augment NK cell viability and function under certain in vitro conditions.
- Differential crosstalk is seen with different NK cell lines (e.g., KHYG-1 vs. NK-92), indicating cell-line-specific responses.
This duality reflects the "licensing" model: MSCs respond to the prevailing cytokine milieu and calibrate their effect on NK cells accordingly.
6. Clinical and Therapeutic Implications
| Application | Relevance |
|---|---|
| GVHD / autoimmune disease | MSC suppression of NK cells helps limit tissue damage; used therapeutically in GvHD, SLE, RA |
| Transplantation | Low HLA-I on MSCs risks NK-mediated rejection; IFN-γ preconditioning of MSCs ("licensing") can protect them |
| Cancer immunotherapy (CAR-NK) | MSCs in the TME impair CAR-NK efficacy; strategies to block MSC-NK suppression (anti-TGF-β, COX-2 inhibitors blocking PGE2) are under investigation |
| Infection | MSC enhancement of IL-12/IL-18-driven IFN-γ from NK cells may improve early innate defense |
| MSC as CAR vehicle | MSCs engineered with CARs or used as delivery vehicles for NK-activating agents are in early development |
Key Takeaways
- The MSC-NK interaction is bidirectional and ratio-dependent - not simply suppressive.
- The dominant effect of MSCs (especially TA-MSCs) is NK cell suppression via IDO, PGE2, TGF-β1, HGF, and HLA-G.
- MSCs protect themselves from NK killing by upregulating HLA-I in response to IFN-γ.
- In inflamed or tumor contexts, NK cells can also lyse MSCs, especially at high NK:MSC ratios.
- This axis has direct relevance to transplant biology, autoimmunity, and cancer immunotherapy.
Key recent reviews:
- Zhang et al. (2024), Int Immunopharmacol - MSC/TA-MSC orchestration of NK cells in the tumor microenvironment PMID: 39305890
- Volarevic et al. (2025), Cells - MSC effects on CAR-NK and CAR-T cells PMID: 40643499
- Dehnavi et al. (2023), Cell Immunol - MSC-immune cell interactions in rheumatoid arthritis PMID: 37783061
This is a shared conversation. Sign in to Orris to start your own chat.